Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

DC ElementWertSprache
dc.contributor.authorSemiglazov, Vladimir
dc.contributor.authorSemiglazov, Vladislav
dc.contributor.authorDashyan, G.A.
dc.contributor.authorZiltsova, E.K.
dc.contributor.authorIvanov, Vadim T.
dc.contributor.authorAa, Bozhok
dc.contributor.authorMelnikova, Olga
dc.contributor.authorRm, Paltuev
dc.contributor.authorKletzel, A.
dc.contributor.authorBerstein, Lev M.
dc.date.accessioned2023-07-11T11:27:23Z-
dc.date.available2023-07-11T11:27:23Z-
dc.date.issued2007
dc.identifier.urihttp://osnascholar.ub.uni-osnabrueck.de/handle/unios/69818-
dc.subjectMedicine
dc.subjectNeoadjuvant therapy
dc.subjectChemotherapy
dc.subjectInternal medicine
dc.subjectAnastrozole
dc.subjectAromatase
dc.subjectOncology
dc.subjectBreast cancer
dc.subjectExemestane
dc.subjectCancer
dc.titlePhase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
dc.typejournal article
dc.identifier.doihttps://doi.org/10.1002/cncr.22789
dc.description.volume110
dc.description.issue2
dc.description.startpage244
dc.description.endpage254
dc.identifier.externalhttps://openalex.org/W2058585724
local.import.sourcefileopenalex_20230710.ris
local.rawaffiliationnull
Zur Kurzanzeige

Google ScholarTM

Prüfen

Altmetric